scholarly article | Q13442814 |
P356 | DOI | 10.1111/IMCB.1018 |
P698 | PubMed publication ID | 29359407 |
P50 | author | Achim Schlapbach | Q56168026 |
Thomas Calzascia | Q56640562 | ||
Catherine H Regnier | Q57445006 | ||
P2093 | author name string | Adeline Unterreiner | |
Claire Malinverni | |||
Frédéric Bornancin | |||
Martin Renatus | |||
Maureen Bardet | |||
José M Carballido | |||
Andreas Katopodis | |||
Jiri Kovarik | |||
Jean Quancard | |||
Guido Bold | |||
Daniel Kaiser | |||
Martin A Schneider | |||
Yeter Kolb | |||
Corinne Vedrine | |||
Carole Pissot-Soldermann | |||
Oliver Simic | |||
Anton Glück | |||
Danielle Boesch | |||
Frédérique Lafossas | |||
P2860 | cites work | The common γ-chain cytokine receptor: tricks-and-treats for T cells. | Q38607461 |
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors | Q39139792 | ||
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. | Q39193083 | ||
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. | Q39226671 | ||
Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals | Q40383554 | ||
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation | Q41240873 | ||
Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation | Q41629410 | ||
Conditional IL-2 Gene Deletion: Consequences for T Cell Proliferation | Q42155875 | ||
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 | ||
MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation | Q44750362 | ||
Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28. | Q45071243 | ||
The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. | Q45985299 | ||
MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling | Q48103382 | ||
The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. | Q52878989 | ||
MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. | Q53209564 | ||
Zinc-binding metallothioneins are key modulators of IL-4 production by basophils. | Q53572805 | ||
Staphylococcal enterotoxins | Q56679620 | ||
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20 | Q24307779 | ||
Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling | Q24619604 | ||
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective | Q26766916 | ||
The paracaspase MALT1: biological function and potential for therapeutic inhibition | Q26778357 | ||
Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase | Q27685382 | ||
Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms | Q28116067 | ||
Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling | Q28505229 | ||
Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase | Q28591729 | ||
Sensitivity of metallothionein-null mice to LPS/D-galactosamine-induced lethality | Q31855339 | ||
Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. | Q33809396 | ||
T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. | Q34174201 | ||
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. | Q34211312 | ||
Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation | Q34346617 | ||
MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes | Q34432953 | ||
Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation | Q34441762 | ||
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling | Q34500164 | ||
CD28-mediated co-stimulation: a quantitative support for TCR signalling | Q34543577 | ||
The proteolytic activity of the paracaspase MALT1 is key in T cell activation | Q34748769 | ||
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. | Q34806889 | ||
The c-Rel Transcription Factor in Development and Disease | Q35556506 | ||
Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. | Q35762426 | ||
Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation | Q36239551 | ||
Functions of BCL-X L at the Interface between Cell Death and Metabolism | Q36702748 | ||
Noncanonical NF-κB signaling is limited by classical NF-κB activity | Q37651821 | ||
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo | Q37699271 | ||
Expression, biological activities and mechanisms of action of A20 (TNFAIP3). | Q37769759 | ||
From MALT lymphoma to the CBM signalosome: three decades of discovery | Q37900457 | ||
The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders. | Q38174486 | ||
P433 | issue | 1 | |
P304 | page(s) | 81-99 | |
P577 | publication date | 2017-12-21 | |
P1433 | published in | Immunology & Cell Biology | Q13731918 |
P1476 | title | The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition | |
P478 | volume | 96 |
Q91259871 | An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient |
Q64087351 | Germinal center-derived lymphomas: The darkest side of humoral immunity |
Q64983436 | Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling. |
Q55265317 | Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease. |
Q59353657 | Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice |
Q93047664 | MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner |
Q92669067 | MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types |
Q60924644 | Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function |
Q57048861 | Molecular architecture and regulation of BCL10-MALT1 filaments |
Q54247368 | NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. |
Q95271987 | Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology |
Q89138330 | Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression |
Q57072726 | The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex |
Search more.